Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study

Clin Biochem. 2011 Mar;44(4):288-92. doi: 10.1016/j.clinbiochem.2010.12.005. Epub 2010 Dec 15.

Abstract

Objectives: The aim of this study was to assess paraoxonase (PON1) and arylesterase (ARE) activities and polymorphism in patients with lacunar infarctions.

Design and methods: The PON1 activity, ARE and lipid profile were determined in 37 patients and 53 healthy individuals. Descriptive and inferential statistics were used to analyze the data.

Results: A total of 37 patients (20 males and 17 females) were studied. The levels of PON1 activity in patients and healthy individuals were 63.5±46.7IU/L and 95.5±75.5IU/L, respectively (p=0.024). The same values for ARE were 54.3±19.3KU/L for patients and 69.1±29.3KU/L for controls (p=0.008). Polymorphism in Q192R location shows statistically different presentation in patient group compared to healthy controls with an odds ratio of 3.42 (CI 95%: 1.24-9.44, p=0.017).

Conclusions: According to this study, we suggest that PON1 192R polymorphism may play a minor role as a risk marker for developing lacunar infarctions in a group of Iranian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Aryldialkylphosphatase / blood
  • Aryldialkylphosphatase / genetics*
  • Brain Infarction / blood
  • Brain Infarction / genetics*
  • Carboxylic Ester Hydrolases / blood
  • Carboxylic Ester Hydrolases / genetics*
  • Case-Control Studies
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease*
  • Humans
  • Iran
  • Lipids / blood
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Risk Factors
  • Serum / chemistry

Substances

  • Lipids
  • Carboxylic Ester Hydrolases
  • arylesterase
  • Aryldialkylphosphatase
  • PON1 protein, human